170sek
-1,3 %
Date:2025-11-28Time:12:08:30Latest report:Q2-2025List:First NorthTicker:NANEXA
Market Cap:269 msekEnterprise Value:266 msekNet Sales:14,3 msekEarnings:-37,6 msekEmployees:0ISIN:SE0007074166

Ratios

10-year key figure history for Nanexa turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Nanexa with index and moving average MA50 and MA200.

Stockprice:1,70
MA50:1,93
MA200:1,88
Price/MA200:-9,5 %
RSI (14):45,1
Price/MA50:-11,9 %

Description

Nanexa is a drug delivery company with a proprietary platform that is used for the formulation of injectable depot drugs that create a supply of drugs to the blood. The PharmaShell process is based on ALD (Atomic Layer Deposition) technology, which encloses pharmaceutical particles with a thin shell and creates opportunities for pharmaceutical companies to develop new products. Nanexa has cooperation with several pharmaceutical companies, mainly around the Nordic market.

Medical Equipment